VA awards $995K contract for Optune prosthetics to Novocure Inc

Contract Overview

Contract Amount: $99,497 ($99.5K)

Contractor: Novocure Inc

Awarding Agency: Department of Veterans Affairs

Start Date: 2026-04-06

End Date: 2026-08-06

Contract Duration: 122 days

Daily Burn Rate: $816/day

Competition Type: FULL AND OPEN COMPETITION

Number of Offers Received: 1

Pricing Type: FIRM FIXED PRICE

Sector: Healthcare

Official Description: PROSTHETICS - OPTUNE

Place of Performance

Location: FRESNO, FRESNO County, CALIFORNIA, 93703

State: California Government Spending

Plain-Language Summary

Department of Veterans Affairs obligated $99,497.46 to NOVOCURE INC for work described as: PROSTHETICS - OPTUNE Key points: 1. Contract value represents a significant investment in advanced prosthetic technology. 2. Competition dynamics suggest a potentially competitive market for electromedical apparatus. 3. Performance period is relatively short, indicating a focused need for the service. 4. This contract aligns with the VA's commitment to providing cutting-edge medical devices to veterans. 5. The fixed-price structure aims to control costs and ensure predictable spending.

Value Assessment

Rating: good

The contract value of approximately $995K for the Optune system appears reasonable given the specialized nature of electromedical devices. Benchmarking against similar contracts for advanced prosthetic technologies would provide a clearer picture of value for money. However, the fixed-price nature of the award suggests an effort to establish clear cost expectations.

Cost Per Unit: N/A

Competition Analysis

Competition Level: full-and-open

The contract was awarded under full and open competition, indicating that multiple vendors had the opportunity to bid. The presence of only one awardee suggests that Novocure Inc. was the most advantageous offer, potentially due to technical capabilities, price, or a combination thereof. Further details on the number of bids received would clarify the extent of competition.

Taxpayer Impact: Full and open competition generally benefits taxpayers by fostering a competitive environment that can lead to better pricing and innovation.

Public Impact

Veterans requiring the Optune prosthetic system will benefit from access to advanced treatment. The contract supports the delivery of specialized electromedical apparatus. The primary geographic impact is likely within the United States, serving VA facilities. This contract may indirectly support jobs in the medical device manufacturing and healthcare sectors.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

Potential for limited long-term cost savings if follow-on contracts are not competitively bid.
Dependence on a single supplier for a critical medical device could pose supply chain risks.

Positive Signals

Awarded through full and open competition, suggesting a fair market process.
Fixed-price contract type helps manage budget predictability.
Clear performance period limits exposure and allows for re-evaluation.

Sector Analysis

The electromedical and electrotherapeutic apparatus manufacturing sector is characterized by innovation and high research and development costs. This contract falls within the broader healthcare technology market, which is experiencing growth driven by an aging population and advancements in medical science. Spending in this area is crucial for providing modern medical solutions.

Small Business Impact

There is no indication that this contract included a small business set-aside. The prime contractor, Novocure Inc., is a significant entity in its field. Subcontracting opportunities for small businesses are not explicitly detailed but could arise if Novocure Inc. engages them for specific components or services.

Oversight & Accountability

The Department of Veterans Affairs is responsible for oversight of this contract. Accountability measures are inherent in the firm fixed-price structure and the defined delivery period. Transparency is facilitated by the public nature of contract awards, though specific performance metrics are not detailed here.

Related Government Programs

VA Medical Equipment Procurement
Prosthetic and Orthotic Devices
Electromedical Apparatus Contracts

Risk Flags

Limited duration of contract may require future competitive procurements.
Sole awardee despite full and open competition warrants scrutiny of bid evaluation.

Frequently Asked Questions

What is this federal contract paying for?

Department of Veterans Affairs awarded $99,497.46 to NOVOCURE INC. PROSTHETICS - OPTUNE

Who is the contractor on this award?

The obligated recipient is NOVOCURE INC.

Which agency awarded this contract?

Awarding agency: Department of Veterans Affairs (Department of Veterans Affairs).

What is the total obligated amount?

The obligated amount is $99,497.46.

What is the period of performance?

Start: 2026-04-06. End: 2026-08-06.

What is the specific function and medical necessity of the Optune prosthetic system being procured?

The Optune system is a wearable device used for treating certain types of cancer, specifically glioblastoma multiforme (GBM), a type of brain tumor. It utilizes Tumor Treating Fields (TTFields) therapy, which disrupts the ability of cancer cells to divide and replicate. The medical necessity for this procurement by the VA likely stems from providing advanced, non-invasive treatment options for veterans diagnosed with GBM, aiming to improve survival rates and quality of life. This therapy is often used in conjunction with standard treatments like chemotherapy and radiation.

How does the awarded price of approximately $995K compare to historical spending on similar prosthetic devices or TTFields therapy by the VA or other federal agencies?

Benchmarking this specific contract's value requires access to detailed historical spending data for the Optune system or comparable TTFields devices across federal agencies. Without direct comparative data, assessing the price's competitiveness is challenging. However, given that TTFields therapy is a specialized and advanced treatment, the awarded amount for a 122-day delivery period appears to be within a plausible range for such technology. Further analysis would involve comparing per-unit costs, treatment duration, and included services against similar procurements.

What is Novocure Inc.'s track record with the federal government, particularly the Department of Veterans Affairs, regarding contract performance and compliance?

Novocure Inc. has a history of federal contracts, primarily with the Department of Veterans Affairs and the Department of Defense, related to their Optune device. A review of federal procurement databases indicates previous awards for similar supplies and services. Assessing their overall track record would involve examining past performance evaluations, any instances of contract disputes or terminations, and compliance history. Generally, the VA's continued awards suggest a satisfactory performance history, but a deeper dive into specific contract performance metrics would be necessary for a comprehensive evaluation.

What are the key performance indicators (KPIs) or service level agreements (SLAs) associated with this contract to ensure effective delivery and value for money?

The provided data does not explicitly detail the Key Performance Indicators (KPIs) or Service Level Agreements (SLAs) for this specific contract. However, typical KPIs for medical device supply contracts often include timely delivery, device functionality and uptime, patient support and training, and adherence to maintenance schedules. For the Optune system, ensuring the device is operational and effectively utilized by patients, along with providing necessary technical support, would be critical. The firm fixed-price nature implies that the contractor is responsible for meeting these performance standards to receive full payment.

What is the anticipated impact of this contract on veterans' access to advanced cancer treatment options within the VA healthcare system?

This contract is expected to directly enhance veterans' access to advanced cancer treatment options, specifically for brain tumors treatable with Tumor Treating Fields (TTFields) therapy. By securing a supply of the Optune system, the VA demonstrates a commitment to integrating innovative medical technologies into its care protocols. This procurement aims to ensure that eligible veterans receive timely access to this potentially life-extending therapy, thereby improving health outcomes and quality of life for those suffering from conditions like glioblastoma. It signifies the VA's effort to keep pace with medical advancements.

Industry Classification

NAICS: Manufacturing › Navigational, Measuring, Electromedical, and Control Instruments Manufacturing › Electromedical and Electrotherapeutic Apparatus Manufacturing

Product/Service Code: MEDICAL/DENTAL/VETERINARY EQPT/SUPP

Competition & Pricing

Extent Competed: FULL AND OPEN COMPETITION

Solicitation Procedures: SUBJECT TO MULTIPLE AWARD FAIR OPPORTUNITY

Offers Received: 1

Pricing Type: FIRM FIXED PRICE (J)

Evaluated Preference: NONE

Contractor Details

Address: 195 COMMERCE WAY, PORTSMOUTH, NH, 03801

Business Categories: Category Business, Corporate Entity Not Tax Exempt, Foreign Owned, Foreign-Owned and U.S.-Incorporated Business, Self-Certified Small Disadvantaged Business, Small Business, Special Designations

Financial Breakdown

Contract Ceiling: $99,497

Exercised Options: $99,497

Current Obligation: $99,497

Contract Characteristics

Commercial Item: COMMERCIAL PRODUCTS/SERVICES

Parent Contract

Parent Award PIID: 36F79723D0016

IDV Type: FSS

Timeline